C
688089
vs
DD
C
688089
DD
Over the past 12 months, Cabio Biotech Wuhan Co Ltd has underperformed DD, delivering a return of -26% compared to the DD's +46% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
688089
DD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
C
Intrinsic Value
19.56
CNY
Undervaluation 7%
DD
Intrinsic Value
31.39
USD
Overvaluation 31%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd
SSE:688089
|
18.24
CNY
|
|||||
|
Dupont De Nemours Inc
NYSE:DD
|
45.26
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
688089, DD
688089, DD
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
Cabio Biotech Wuhan Co Ltd
Revenue
|
|||||||||||
|
|
Dupont De Nemours Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
688089, DD
688089, DD
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
Cabio Biotech Wuhan Co Ltd
SSE:688089
|
|||||||||
|
|
Dupont De Nemours Inc
NYSE:DD
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Cabio Biotech Wuhan Co Ltd
48.8%
DD
34.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
Operating Margin
Cabio Biotech Wuhan Co Ltd
29.1%
DD
12.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
Net Margin
Cabio Biotech Wuhan Co Ltd
28.4%
DD
-11.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
FCF Margin
Cabio Biotech Wuhan Co Ltd
10.2%
DD
15.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
ROE
Cabio Biotech Wuhan Co Ltd
10.8%
DD
-4.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
ROA
Cabio Biotech Wuhan Co Ltd
9.7%
DD
-2.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
ROIC
Cabio Biotech Wuhan Co Ltd
10.1%
DD
1.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
ROCE
Cabio Biotech Wuhan Co Ltd
10.7%
DD
3.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cabio Biotech Wuhan Co Ltd | ||||
|
|
Dupont De Nemours Inc | ||||
Solvency Comparison
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
688089, DD
688089, DD
Performance By Year
688089, DD
688089, DD
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 688089 to other stocks
SHW
Sherwin-Williams Co
More expensive
vs Cabio Biotech Wuhan Co Ltd
ECL
Ecolab Inc
More expensive
vs Cabio Biotech Wuhan Co Ltd
4063
Shin-Etsu Chemical Co Ltd
More expensive
vs Cabio Biotech Wuhan Co Ltd
4957
Yasuhara Chemical Co Ltd
Y
Cheaper
vs Cabio Biotech Wuhan Co Ltd
Select Stock to Compare
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
|
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
|
| CH |
|
Sika AG
F:SIKA
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
